Mankind Pharma reports 18% fall in Q1 consolidated net profit

01 Aug 2025 Evaluate

Mankind Pharma has reported result for first quarter ended June 30, 2025 (Q1FY26). 

The company has reported 18.37% fall in its net profit at Rs 412.76 crore for the quarter ended June 30, 2025 as compared to Rs 505.66 crore for the same quarter in the previous year. However, the total income of the company increased by 3.86% at Rs 2605.58 crore for Q1FY26 as compared to Rs 2508.66 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 18.30% fall in its net profit at Rs 438.32 crore for Q1FY26 as compared to Rs 536.49 crore for the same quarter in the previous year. However, the total income of the company increased by 23.02% at Rs 3650.23 crore for Q1FY26 as compared to Rs 2967.25 crore for the corresponding quarter previous year.

Mankind Pharma Share Price

2204.70 -3.65 (-0.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×